{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:55:54Z","timestamp":1790744154345,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1 ZIA AI001222-02"],"award-info":[{"award-number":["1 ZIA AI001222-02"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["Bench-to-Bedside"],"award-info":[{"award-number":["Bench-to-Bedside"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT200844\/Z\/16\/Z"],"award-info":[{"award-number":["WT200844\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10875-021-00989-6","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T21:02:57Z","timestamp":1614632577000},"page":"852-862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Gene Editing Rescues In vitro T Cell Development of RAG2-Deficient Induced Pluripotent Stem Cells in an Artificial Thymic Organoid System"],"prefix":"10.1007","volume":"41","author":[{"given":"Cameron L.","family":"Gardner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Pavel-Dinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Dobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Bosticardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Lack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk See","family":"DeRavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavia M.","family":"Delmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Malech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Montel-Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gay","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Acuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Porteus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-0262","authenticated-orcid":false,"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"989_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1749-6632.1992.tb24626.x","volume":"651","author":"FW Alt","year":"1992","unstructured":"Alt FW, Rathbun G, Oltz E, Taccioli G, Shinkai Y. Function and control of recombination-activating gene activity. Ann N Y Acad Sci. 1992;651:277\u201394. https:\/\/doi.org\/10.1111\/j.1749-6632.1992.tb24626.x.","journal-title":"Ann N Y Acad Sci"},{"key":"989_CR2","doi-asserted-by":"crossref","unstructured":"Wada T, Takei K, Kudo M, Shimura S, Kasahara Y, Koizumi S, et al. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders. Clin Exp Immunol. 2000;119(1):148\u201355.","DOI":"10.1046\/j.1365-2249.2000.01101.x"},{"issue":"9","key":"989_CR3","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1182\/blood.2019000923","volume":"135","author":"OM Delmonte","year":"2020","unstructured":"Delmonte OM, Villa A, Notarangelo LD. Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency. Blood. 2020;135(9):610\u20139. https:\/\/doi.org\/10.1182\/blood.2019000923.","journal-title":"Blood."},{"key":"989_CR4","doi-asserted-by":"publisher","unstructured":"Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao K, et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood. 2012;120(17):3615\u201324; quiz 26. https:\/\/doi.org\/10.1182\/blood-2011-12-396879.","DOI":"10.1182\/blood-2011-12-396879"},{"key":"989_CR5","doi-asserted-by":"publisher","unstructured":"van Til NP, Sarwari R, Visser TP, Hauer J, Lagresle-Peyrou C, van der Velden G, et al. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome. J Allergy Clin Immunol. 2014;133(4):1116\u201323. https:\/\/doi.org\/10.1016\/j.jaci.2013.10.009.","DOI":"10.1016\/j.jaci.2013.10.009"},{"key":"989_CR6","doi-asserted-by":"publisher","unstructured":"Capo V, Castiello MC, Fontana E, Penna S, Bosticardo M, Draghici E, et al. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation. J Allergy Clin Immunol. 2018;142(3):928\u201341 e8. https:\/\/doi.org\/10.1016\/j.jaci.2017.11.015.","DOI":"10.1016\/j.jaci.2017.11.015"},{"issue":"9","key":"989_CR7","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/leu.2011.106","volume":"25","author":"K Pike-Overzet","year":"2011","unstructured":"Pike-Overzet K, Rodijk M, Ng YY, Baert MR, Lagresle-Peyrou C, Schambach A, et al. Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer. Leukemia. 2011;25(9):1471\u201383. https:\/\/doi.org\/10.1038\/leu.2011.106.","journal-title":"Leukemia."},{"key":"989_CR8","doi-asserted-by":"publisher","unstructured":"Lagresle-Peyrou C, Benjelloun F, Hue C, Andre-Schmutz I, Bonhomme D, Forveille M, et al. Restoration of human B-cell differentiation into NOD-SCID mice engrafted with gene-corrected CD34+ cells isolated from Artemis or RAG1-deficient patients. Mol Ther. 2008;16(2):396\u2013403. https:\/\/doi.org\/10.1038\/sj.mt.6300353.","DOI":"10.1038\/sj.mt.6300353"},{"issue":"44","key":"989_CR9","doi-asserted-by":"publisher","first-page":"16406","DOI":"10.1073\/pnas.0608130103","volume":"103","author":"G Mostoslavsky","year":"2006","unstructured":"Mostoslavsky G, Fabian AJ, Rooney S, Alt FW, Mulligan RC. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci U S A. 2006;103(44):16406\u201311. https:\/\/doi.org\/10.1073\/pnas.0608130103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"989_CR10","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1182\/blood-2002-03-0782","volume":"100","author":"F Yates","year":"2002","unstructured":"Yates F, Malassis-Seris M, Stockholm D, Bouneaud C, Larousserie F, Noguiez-Hellin P, et al. Gene therapy of RAG-2\u2212\/\u2212 mice: sustained correction of the immunodeficiency. Blood. 2002;100(12):3942\u20139. https:\/\/doi.org\/10.1182\/blood-2002-03-0782.","journal-title":"Blood."},{"issue":"1","key":"989_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1182\/blood-2005-05-2032","volume":"107","author":"C Lagresle-Peyrou","year":"2006","unstructured":"Lagresle-Peyrou C, Yates F, Malassis-Seris M, Hue C, Morillon E, Garrigue A, et al. Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity. Blood. 2006;107(1):63\u201372. https:\/\/doi.org\/10.1182\/blood-2005-05-2032.","journal-title":"Blood"},{"key":"989_CR12","doi-asserted-by":"publisher","unstructured":"Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, et al. CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539(7629):384\u20139. https:\/\/doi.org\/10.1038\/nature20134.","DOI":"10.1038\/nature20134"},{"issue":"7504","key":"989_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature13420","volume":"510","author":"P Genovese","year":"2014","unstructured":"Genovese P, Schiroli G, Escobar G, Tomaso TD, Firrito C, Calabria A, et al. Targeted genome editing in human repopulating haematopoietic stem cells. Nature. 2014;510(7504):235\u201340. https:\/\/doi.org\/10.1038\/nature13420.","journal-title":"Nature."},{"key":"989_CR14","doi-asserted-by":"publisher","unstructured":"Rai R, Romito M, Rivers E, Turchiano G, Blattner G, Vetharoy W, et al. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott-Aldrich syndrome. Nat Commun. 2020;11(1):4034. https:\/\/doi.org\/10.1038\/s41467-020-17626-2.","DOI":"10.1038\/s41467-020-17626-2"},{"key":"989_CR15","doi-asserted-by":"publisher","unstructured":"Hubbard N, Hagin D, Sommer K, Song Y, Khan I, Clough C, et al. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome. Blood. 2016;127(21):2513\u201322. https:\/\/doi.org\/10.1182\/blood-2015-11-683235.","DOI":"10.1182\/blood-2015-11-683235"},{"issue":"15","key":"989_CR16","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170.","journal-title":"Bioinformatics."},{"issue":"17","key":"989_CR17","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/bioinformatics\/btu314","volume":"30","author":"GG Faust","year":"2014","unstructured":"Faust GG, Hall IM. SAMBLASTER: fast duplicate marking and structural variant read extraction. Bioinformatics. 2014;30(17):2503\u20135. https:\/\/doi.org\/10.1093\/bioinformatics\/btu314.","journal-title":"Bioinformatics."},{"key":"989_CR18","doi-asserted-by":"publisher","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213\u20139. https:\/\/doi.org\/10.1038\/nbt.2514.","DOI":"10.1038\/nbt.2514"},{"key":"989_CR19","doi-asserted-by":"publisher","unstructured":"Montel-Hagen A, Seet CS, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-induced differentiation of conventional T cells from human pluripotent stem cells. Cell Stem Cell. 2019;24(3):376\u201389 e8. https:\/\/doi.org\/10.1016\/j.stem.2018.12.011.","DOI":"10.1016\/j.stem.2018.12.011"},{"key":"989_CR20","doi-asserted-by":"publisher","unstructured":"Pavel-Dinu M, Wiebking V, Dejene BT, Srifa W, Mantri S, Nicolas CE, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10(1):1634. https:\/\/doi.org\/10.1038\/s41467-019-09614-y.","DOI":"10.1038\/s41467-019-09614-y"},{"key":"989_CR21","doi-asserted-by":"publisher","unstructured":"Seet CS, He C, Bethune MT, Li S, Chick B, Gschweng EH, et al. Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nat Methods. 2017;14(5):521\u201330. https:\/\/doi.org\/10.1038\/nmeth.4237.","DOI":"10.1038\/nmeth.4237"},{"key":"989_CR22","doi-asserted-by":"publisher","unstructured":"Bosticardo M, Pala F, Calzoni E, Delmonte OM, Dobbs K, Gardner CL, et al. Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020;4(12):2611\u20136. https:\/\/doi.org\/10.1182\/bloodadvances.2020001730.","DOI":"10.1182\/bloodadvances.2020001730"},{"key":"989_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev.immunol.23.021704.115830","volume":"24","author":"D Jung","year":"2006","unstructured":"Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol. 2006;24:541\u201370. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115830.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"989_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.coi.2009.03.009","volume":"21","author":"MS Krangel","year":"2009","unstructured":"Krangel MS. Mechanics of T cell receptor gene rearrangement. Curr Opin Immunol. 2009;21(2):133\u20139. https:\/\/doi.org\/10.1016\/j.coi.2009.03.009.","journal-title":"Curr Opin Immunol"},{"key":"989_CR25","doi-asserted-by":"publisher","unstructured":"Berland A, Rosain J, Kaltenbach S, Allain V, Mahlaoui N, Melki I, et al. PROMIDISalpha: a T-cell receptor alpha signature associated with immunodeficiencies caused by V(D)J recombination defects. J Allergy Clin Immunol. 2018;143:325\u2013334.e2. https:\/\/doi.org\/10.1016\/j.jaci.2018.05.028.","DOI":"10.1016\/j.jaci.2018.05.028"},{"key":"989_CR26","doi-asserted-by":"publisher","unstructured":"Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Logan B, Griffith LM, et al. The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). J Allergy Clin Immunol. 2019;143(1):405\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2018.08.027.","DOI":"10.1016\/j.jaci.2018.08.027"},{"issue":"6","key":"989_CR27","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","volume":"7","author":"JR Farmer","year":"2019","unstructured":"Farmer JR, Foldvari Z, Ujhazi B, De Ravin SS, Chen K, Bleesing JJH, et al. Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency. J Allergy Clin Immunol Pract. 2019;7(6):1970\u201385 e4. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.038.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"989_CR28","doi-asserted-by":"publisher","unstructured":"Schuetz C, Neven B, Dvorak CC, Leroy S, Ege MJ, Pannicke U, et al. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Blood. 2014;123(2):281\u20139. https:\/\/doi.org\/10.1182\/blood-2013-01-476432.","DOI":"10.1182\/blood-2013-01-476432"},{"key":"989_CR29","doi-asserted-by":"publisher","unstructured":"Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132(17):1737\u201349. https:\/\/doi.org\/10.1182\/blood-2018-03-840702.","DOI":"10.1182\/blood-2018-03-840702"},{"key":"989_CR30","doi-asserted-by":"publisher","unstructured":"Themeli M, Chhatta A, Boersma H, Prins HJ, Cordes M, de Wilt E, et al. iPSC-based modeling of RAG2 severe combined immunodeficiency reveals multiple T cell developmental arrests. Stem Cell Rep. 2020;14(2):300\u201311. https:\/\/doi.org\/10.1016\/j.stemcr.2019.12.010.","DOI":"10.1016\/j.stemcr.2019.12.010"},{"key":"989_CR31","doi-asserted-by":"publisher","unstructured":"Bifsha P, Leiding JW, Pai SY, Colamartino ABL, Hartog N, Church JA, et al. Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency. Blood Adv. 2020;4(12):2606\u201310. https:\/\/doi.org\/10.1182\/bloodadvances.2020001736.","DOI":"10.1182\/bloodadvances.2020001736"},{"issue":"6","key":"989_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1182\/blood-2015-10-676304","volume":"128","author":"PM Brauer","year":"2016","unstructured":"Brauer PM, Pessach IM, Clarke E, Rowe JH, Ott de Bruin L, Lee YN, et al. Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies. Blood. 2016;128(6):783\u201393. https:\/\/doi.org\/10.1182\/blood-2015-10-676304.","journal-title":"Blood."},{"issue":"16","key":"989_CR33","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","volume":"380","author":"E Mamcarz","year":"2019","unstructured":"Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G, et al. Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1. N Engl J Med. 2019;380(16):1525\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1815408.","journal-title":"N Engl J Med"},{"key":"989_CR34","doi-asserted-by":"publisher","unstructured":"van Til NP, de Boer H, Mashamba N, Wabik A, Huston M, Visser TP, et al. Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene. Mol Ther. 2012;20(10):1968\u201380. https:\/\/doi.org\/10.1038\/mt.2012.110.","DOI":"10.1038\/mt.2012.110"},{"issue":"372","key":"989_CR35","doi-asserted-by":"publisher","first-page":"eaah3480","DOI":"10.1126\/scitranslmed.aah3480","volume":"9","author":"SS De Ravin","year":"2017","unstructured":"De Ravin SS, Li L, Wu X, Choi U, Allen C, Koontz S, et al. CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease. Sci Transl Med. 2017;9(372):eaah3480. https:\/\/doi.org\/10.1126\/scitranslmed.aah3480.","journal-title":"Sci Transl Med"},{"issue":"2","key":"989_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nprot.2017.143","volume":"13","author":"RO Bak","year":"2018","unstructured":"Bak RO, Dever DP, Porteus MH. CRISPR\/Cas9 genome editing in human hematopoietic stem cells. Nat Protoc. 2018;13(2):358\u201376. https:\/\/doi.org\/10.1038\/nprot.2017.143.","journal-title":"Nat Protoc"},{"key":"989_CR37","doi-asserted-by":"publisher","unstructured":"Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT, Cromer MK, et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat Med. 2019;25(2):249\u201354. https:\/\/doi.org\/10.1038\/s41591-018-0326-x.","DOI":"10.1038\/s41591-018-0326-x"},{"issue":"4","key":"989_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/nat.2019.0790","volume":"29","author":"CA Vakulskas","year":"2019","unstructured":"Vakulskas CA, Behlke MA. Evaluation and reduction of CRISPR off-target cleavage events. Nucleic Acid Ther. 2019;29(4):167\u201374. https:\/\/doi.org\/10.1089\/nat.2019.0790.","journal-title":"Nucleic Acid Ther"},{"key":"989_CR39","doi-asserted-by":"publisher","unstructured":"Sweeney CL, Zou J, Choi U, Merling RK, Liu A, Bodansky A, et al. Targeted repair of CYBB in X-CGD iPSCs requires retention of Intronic sequences for expression and functional correction. Mol Ther. 2017;25(2):321\u201330. https:\/\/doi.org\/10.1016\/j.ymthe.2016.11.012.","DOI":"10.1016\/j.ymthe.2016.11.012"}],"updated-by":[{"DOI":"10.1007\/s10875-021-01030-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T00:00:00Z","timestamp":1617580800000}}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-00989-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-00989-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-00989-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T16:17:15Z","timestamp":1625156235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-00989-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-00989-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10875-021-01030-6","asserted-by":"object"}]},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"27 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10875-021-01030-6","URL":"https:\/\/doi.org\/10.1007\/s10875-021-01030-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"M.H.P. serves on the SAB for CRISPR Tx and Allogene Tx. Neither company had input into the design, execution, data analysis, or publication of the work presented in this manuscript. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"A skin biopsy specimen was obtained from the RAG2-deficient patient upon informed consent according to protocol 04-09-113R approved by Boston Children\u2019s Hospital IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}